Internal Medicine, Hematology & Oncology · Fountain Valley, CA
NPI
1831586387
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
11180 Warner Ave Ste 351
Fountain Valley, CA, 92708
Phone (714) 698-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
36,748 services
Medicare patients, 2024
104
Average age 76
Drug cost, 2024
$5.2M
1,703 prescriptions
Company payments, 2025
$9,901
From 65 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pete Pow-Anpongkul was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 884 times for 11 patients. In total Pete Pow-Anpongkul billed 36,748 services in 76 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 884 | 11 | $0.09 | $78.6 |
| 99215 Office E&M - Established | Office | 242 | 79 | $148.15 | $36K |
| 96367 Intravenous Infusion, Hydration | Office | 134 | 13 | $25.51 | $3,418 |
| 96413 Chemotherapy Administration | Office | 109 | 16 | $116.23 | $13K |
| 96127 Behavioral Health Services | Office | 71 | 52 | $4.17 | $296 |
| 99214 Office E&M - Established | Office | 64 | 32 | $109.85 | $7,030 |
| 96372 Injection Administration | Office | 63 | 14 | $12.55 | $790 |
| 96417 Chemotherapy Administration | Office | 52 | 11 | $57.83 | $3,007 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 41 | 11 | $0.62 | $25.62 |
| 99205 Office E&M - New | Office | 29 | 29 | $174.45 | $5,059 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 16 | $95.37 | $2,003 |
| 36415 Venipuncture Blood Collection | Office | 18 | 15 | $8.61 | $155 |
By year: 2022 $213K for 9,280 services; 2023 $528K for 34,406 services; 2024 $1.0M for 36,748 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 18 | 15 | $8.61 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Pete Pow-Anpongkul prescribed most often to Medicare patients was Anastrozole, with 167 prescriptions and refills. In total Pete Pow-Anpongkul wrote 1,703 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 167 | 412 | 60 | $2,670 |
| Eliquis Apixaban | 79 | 97 | 21 | $56K |
| Xarelto Rivaroxaban | 68 | 85 | 16 | $46K |
| Dexamethasone Sodium Phosphate Generic | 65 | 66 | 20 | $267 |
| Hydroxyurea Generic | 52 | 146 | 19 | $2,280 |
| Diphenhydramine Hcl Generic | 48 | 49 | 19 | $133 |
| Folic Acid Generic | 42 | 94 | 12 | $238 |
| Ondansetron Hcl Ondansetron Hcl/Pf | 36 | 37 | 11 | $152 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | 21 | $339 |
| Fosaprepitant Dimeglumine Generic | 32 | 33 | 11 | $4,233 |
| Dexamethasone Generic | 32 | 40 | Under 11 | $512 |
| Famotidine Famotidine/Pf | 27 | 28 | 12 | $53.19 |
| Palonosetron Hcl Generic | 26 | 26 | 12 | $841 |
| Revlimid Lenalidomide | 26 | 26 | Under 11 | $563K |
| Leucovorin Calcium Generic | 24 | 24 | Under 11 | $5,298 |
Brand drugs: - claims; generic drugs: 1,109 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pete Pow-Anpongkul $9,901 ($9,901 in general payments such as food, travel and fees) from 65 companies. The largest payer was Novartis Pharmaceuticals Corporation with $973.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $973 |
| Janssen Biotech, Inc. JNJ | 20 | $506 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $480 |
| Abbvie Inc. ABBV | 19 | $465 |
| Eisai Inc. 4523.T | 14 | $361 |
| Pfizer Inc. PFE | 16 | $359 |
| Karyopharm Therapeutics Inc. KPTI | 11 | $329 |
| Merck Sharp & Dohme LLC MRK | 11 | $327 |
| BeOne Medicines USA, Inc. ONC | 10 | $309 |
| Incyte Corporation INCY | 12 | $274 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.